Douglas C. Dover

Douglas C. Dover

Auto-generated profile, based on publicly available information

Douglas C. Dover

Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2019 in International Journal for Equity in Health
Verified
Journal Article
Open access
PDF file
DDDouglas C. Dover
Douglas C. Dover
ABAna Paula Belon
Ana Paula Belon
Despite the wealth of frameworks on social determinants of health (SDOH), two current limitations include the relative superficial description of factors affecting health and a lack of focus on measuring health equity. The Health Equity Measurement Framework (HEMF) addresses these gaps by providing a more encompassing view of the multitude of SDOH and drivers of health service utilisation and by guiding quantitative analysis for public health surveillance and policy development. The objective of this paper is to present the HEMF, which was specifically designed to measure the direct and indirect effects of SDOH to support improved statistical modelling and measurement of health equity. Based on a framework synthesis, the HEMF development involved initially integrating theoretical components from existing SDOH and health system utilisation frameworks. To further develop the framework, relevant publications on SDOH and health equity were identified through a literature review in major electronic databases. White and grey literatures were critically reviewed to identify strengths and gaps in the existing frameworks in order to inform the development of a unique health equity measurement framework. Finally, over a two-year period of consultation, scholars, health practitioners, and local policy influencers from municipal and provincial governments provided critical feedback on the framework regarding its components and causal relationships. This unified framework includes the socioeconomic, cultural, and political context, health policy context, social stratification, social location, material and social circumstances, environment, biological factors, health-related behaviours and beliefs, stress, quality of care, and healthcare utilisation. Alongside the HEMF’s self-exploratory diagram showing the causal pathways in-depth, a number of examples are provided to illustrate the framework’s usefulness in measuring and monitoring health equity as well as informing policy-making. The HEMF highlights intervention areas to be influenced by strategic public policy for any organisation whose purview has an effect on health, including helping non-health sectors (such as education and labour) to better understand how their policies influence population health and perceive their role in health equity promotion. The HEMF recognises the complexity surrounding the SDOH and provides a clear, overarching direction for empirical work on health equity.

7 May 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
SBSonia Butalia
Sonia Butalia
LCLuan Chu
Luan Chu
DDDouglas C. Dover
Douglas C. Dover
DLDarren Lau
Darren Lau
RYRoseanne O. Yeung
Roseanne O. Yeung
PKPadma Kaul
Padma Kaul
Background: We examined the association between hemoglobin A1c (HbA1c) and the development of cardiovascular disease (CVD) in men and women, without diabetes or CVD at baseline. Methods and Results: This retrospective cohort study included adults aged 40 to <80 years in Alberta, Canada. Men and women were divided into categories based on a random HbA1c during a 3‐year enrollment period. The primary outcome of CVD hospitalization and secondary outcome of combined CVD hospitalization/mortality were examined during a 5‐year follow‐up period until March 31, 2021. A total of 608 474 individuals (55.2% women) were included. Compared with HbA1c 5.0% to 5.4%, men with HbA1c of 5.5% to 5.9% had an increased risk of CVD hospitalization (adjusted hazard ratio [aHR], 1.12 [95% CI, 1.07–1.19]) whereas women did not (aHR, 1.01 [95% CI, 0.95–1.08]). Men and women with HbA1c of 6.0% to 6.4% had a 38% and 17% higher risk and men and women with HbA1c ≥6.5% had a 79% and 51% higher risk of CVD hospitalization, respectively. In addition, HbA1c of 6.0% to 6.4% and HbA1c ≥6.5% were associated with a higher risk (14% and 41%, respectively) of CVD hospitalization/death in men, but HbA1c ≥6.5% was associated with a 24% higher risk only among women. Conclusions: In both men and women, HbA1c ≥6.0% was associated with an increased risk of CVD and mortality outcomes. The association between CVD and HbA1c levels of 5.5% to 5.9%, considered to be in the “normal” range, highlights the importance of optimizing cardiovascular risk profiles at all levels of glycemia, especially in men.

8 September 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
OOOluwayomi Olugbuyi
Oluwayomi Olugbuyi
CSChristopher Smith
Christopher Smith
PKPadma Kaul
Padma Kaul
DDDouglas C. Dover
Douglas C. Dover
AMAndrew S. Mackie
Andrew S. Mackie
LHLisa Hornberger
Lisa Hornberger
Background: Socioeconomic status (SES) impacts clinical outcomes associated with severe congenital heart disease (sCHD). We examined the impact of SES and remoteness of residence (RoR) on congenital heart disease (CHD) outcomes in Canada, a jurisdiction with universal health insurance. Methods and Results: All infants born in Canada (excluding Quebec) from 2008 to 2018 and hospitalized with CHD requiring intervention in the first year were identified. Neighborhood level SES income quintiles were calculated, and RoR was categorized as residing 300 km from the closest of 7 cardiac surgical programs. In‐hospital mortality at <1 year was the primary outcome, adjusted for preterm birth, low birth weight, and extracardiac pathology. Among 7711 infants, 4485 (58 . 2%) had moderate CHD (mCHD) and 3226 (41.8%) had sCHD. Overall mortality rate was 10.5%, with higher rates in sCHD than mCHD (13.3% versus 8.5%, respectively). More CHD infants were in the lowest compared with the highest SES category (27.1% versus 15.0%, respectively). The distribution of CHD across RoR categories was 52.3%, 21.3%, and 26.4% for 300 km, respectively. Although SES and RoR had no impact on sCHD mortality, infants with mCHD living >300 km had a higher risk of mortality relative to those living <100 km (adjusted odds ratio [aOR], 1.43 [95% CI, 1.11–1.84]). Infants with mCHD within the lowest SES quintile and living farthest away had the highest risk for mortality (aOR, 1.74 [95% CI, 1.08–2.81]). Conclusions: In Canada, neither RoR nor SES had an impact on outcomes of infants with sCHD. Greater RoR, however, may contribute to higher risk of mortality among infants with mCHD.

1 January 2015 in Vaccine
Verified
Journal Article
Closed access
FLFlorence Y. Lai
Florence Y. Lai
DDDouglas C. Dover
Douglas C. Dover
BLBonita Lee
Bonita Lee
KFKevin Fonseca
Kevin Fonseca
NSNatalia Solomon
Natalia Solomon
CCCarmen Lynn Charlton
Carmen Lynn Charlton

1 November 2012 in Journal of Cutaneous Medicine and Surgery
Verified
Journal Article
Closed access
PKPaul Kuzel
Paul Kuzel
AMAndrei I. Metelitsa
Andrei I. Metelitsa
DDDouglas C. Dover
Douglas C. Dover
TSThomas G. Salopek
Thomas G. Salopek
Background: The epidemiology of sebaceous carcinoma (SC) has not previously been examined in a Canadian population. Objective: To determine the epidemiologic trends of SC in Alberta, Canada, from 1988 to 2007. Methods: This study was a population-based, retrospective, epidemiologic analysis of SC in Alberta over a 20-year span. Results: Over the study period, the age-standardized SC incidence increased from 0.22 per 100,000 to 0.65 per 100,000. Sebaceous carcinoma is a cancer that predominantly affects the elderly (over 85% of cases were in persons 60 years or older). Interestingly, the face (37.7% of cases), not the eyelids (26.2% of cases), was the most frequently affected site overall. Gender-specific trends reflected a slight male predominance (1.4:1) and significant differences in anatomic distribution between the sexes. Conclusion: For unexplained reasons, there has been a threefold increase in SC incidence in Alberta over the last two decades. In addition, there are significant gender-specific differences in the anatomic distribution of SC. Contexte: L'épidémiologie du carcinome sébacé (CS) n'a jamais fait l'objet d'étude au Canada. Objectif: L'étude visait à déterminer les tendances épidémiologiques du CS en Alberta, au Canada, de 1988 à 2007. Méthodes: Il s'agit d'une analyse épidémiologique, rétrospective, fondée sur la population, du CS, en Alberta, sur une période de 20 ans. Résultats: Au cours de la période à l'étude, l'incidence du CS normalisée selon l'âge est passée de 0.22 pour 100,000 à 0.65 pour 100,000. Le carcinome sébacé est un cancer qui touche surtout les personnes âgées (plus de 85% des cas se comptaient parmi les personnes de 60 ans et plus). Point intéressant, la région le plus souvent touchée, dans l'ensemble, était la face (37.7% des cas), et non les paupières (26.2% des cas). Les tendances propres à chaque sexe ont révélé une fréquence légèrement plus élevée chez les hommes que chez les femmes (1.4/1) et des différences importantes entre les sexes quant à la répartition anatomique du siège des lésions. Conclusion: Pour des raisons inconnues, l'incidence du CS a triplé en Alberta au cours des deux dernières décennies. De plus, il existe des différences importantes entre les sexes quant à la répartition anatomique du CS.

18 April 2021 in Statistics in Medicine
Verified
Journal Article
Closed access
PDF file
DDDouglas C. Dover
Douglas C. Dover
SISunjidatul Islam
Sunjidatul Islam
CWCynthia M. Westerhout
Cynthia M. Westerhout
LMLinn E. Moore
Linn E. Moore
PKPadma Kaul
Padma Kaul
ASAnamaria Savu
Anamaria Savu